New research sheds light on a novel biomarker that may accurately predict new-onset peripheral arterial disease in patients with mild to moderate chronic kidney disease. Researcher Scott E. Janus, MD,...
Consultant360 spoke with Karen Hansen, MD, whose study suggests that parathyroid hormone may be an independent predictor of fractures, vascular events, and mortality in some patients with chronic kidney...
James J. Matera, DO, explains the importance of treating hyperkalemia – a common occurrence in patients with chronic kidney disease – in the context of comorbid cardiometabolic disease.
Dr Matera discusses common concerns and questions patients with chronic kidney disease ask their physicians, as well as the importance of collaboration between nephrologists and primary care physicians in...
In a recent study, researchers examined how chronic kidney disease care differed among patients of different races and ethnicities. Lead study author Chi Chu, MD, MAS, answered our questions on his team’s...
In this Q&A, Ping Liu, PhD, and Pietro Ravani, MD, PhD, answer our questions about the diagnosis and management of chronic kidney disease and discuss how the current definition of CKD does not consider...
Diabetes, cardiovascular disease, and kidney disease are leading causes of death in the United States, but what else do they have in common? In this Q&A, Dr Thomas Zelniker explains how these 3 diseases...
Consultant360 spoke with Dr James J Matera will present on the interaction between chronic kidney disease and the risk for cardiovascular disease, and how practitioners should monitor cardiovascular risk in...
